Login / Signup

Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm.

Francisco José Calero-CastroSheila PereiraIman LagaPaula VillanuevaGonzalo Suárez-ArtachoCarmen Cepeda-FrancoPatricia de la Cruz-OjedaElena Navarro-VillaránSandra Dios BarbeitoMaria Jose SerranoCristóbal FresnoJavier Padillo-Ruiz
Published in: International journal of molecular sciences (2023)
Circulating Tumor Cells (CTCs) are considered a prognostic marker in pancreatic cancer. In this study we present a new approach for counting CTCs and CTC clusters in patients with pancreatic cancer using the Isoflux TM System with the Hough transform algorithm (Hough-Isoflux TM ). The Hough-Isoflux TM approach is based on the counting of an array of pixels with a nucleus and cytokeratin expression excluding the CD45 signal. Total CTCs including free and CTC clusters were evaluated in healthy donor samples mixed with pancreatic cancer cells (PCCs) and in samples from patients with pancreatic ductal adenocarcinoma (PDAC). The Isoflux TM System with manual counting was used in a blinded manner by three technicians who used Manual-Isoflux TM as a reference. The accuracy of the Hough-Isoflux TM approach for detecting PCC based on counted events was 91.00% [84.50, 93.50] with a PCC recovery rate of 80.75 ± 16.41%. A high correlation between the Hough-Isoflux TM and Manual-Isoflux TM was observed for both free CTCs and for clusters in experimental PCC (R 2 = 0.993 and R 2 = 0.902 respectively). However, the correlation rate was better for free CTCs than for clusters in PDAC patient samples (R 2 = 0.974 and R 2 = 0.790 respectively). In conclusion, the Hough-Isoflux TM approach showed high accuracy for the detection of circulating pancreatic cancer cells. A better correlation rate was observed between Hough-Isoflux TM approach and with the Manual-Isoflux TM for isolated CTCs than for clusters in PDAC patient samples.
Keyphrases
  • circulating tumor cells
  • circulating tumor
  • deep learning
  • randomized controlled trial
  • poor prognosis
  • study protocol
  • long non coding rna
  • high throughput
  • neural network
  • quantum dots